Our diverse portfolio of investments includes companies dedicated to developing novel therapeutics for unmet medical needs. Simply click on each company's name to learn more.
Portfolio Companies
Biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications http://www.ambitbio.com
Gene therapy company focused on the research and development of novel therapeutics for patients with unmet medical needs utilizing AGTC's proprietary, non-pathogenic adeno-associated virus (AAV) delivery system http://www.agtc.com
Drug discovery and development company that focuses on neurogenesis using its proprietary human neural stem cell platform technology to treat various CNS diseases http://www.braincellsinc.com
Biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases http://www.catabasispharma.com
Biopharmaceutical company that focuses on arginase inhibition to promote endothelial function http://www.corridorpharma.com/
Biopharmaceutical company focused on the development of antibody therapeutics for the treatment of life-threatening diseases http://www.elusys.com
Biopharmaceutical company that develops drugs to treat pain, inflammation, cardiovascular, and other diseases using its expertise in novel ion channels http://www.hydrabiosciences.com
Biopharmaceutical firm focused on the development of innovative drug candidates to address significant diseases of the eye, with a major focus on glaucoma http://www.inotekcorp.com
Biotechnology company focused on developing novel vaccines for gastrointestinal and respiratory indications using its virus-like particles technology http://www.ligocyte.com
Biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells http://www.nktrx.com
Small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics http://www.rib-x.com
Biotechnology company developing novel antibody therapeutic for rheumatoid arthritis and other indications
Biotechnology company developing novel, proprietary vaccines for infectious diseases http://www.vaxinnate.com
Biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory, and autoimmune diseases http://www.ventirx.com
Biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders http://www.virdante.com
Biotechnology company dedicated to the streamlined discovery and development of novel therapeutics for the treatment of autoimmune and inflammatory disorders http://www.vlstcorp.com
Biotechnology company that focuses on antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency http://www.xencor.com
Selected Exited Portfolio Companies